COV2008
This study is investigating the safety and efficacy of the Johnson & Johnson Adv.26 booster vaccine in healthy adults who have previously received the Pfizer COVID-19 vaccine. This study is currently enrolling participants.
vYF02
/in Enrollment CompleteThis study is comparing the immunogenicity and safety of an investigational yellow fever vaccine with the previously approved YF-VAX vaccine. The main purpose of the study is to determine if the study vaccine is safe and creates comparable immune responses to that of the YF-VAX vaccine. This study is currently enrolling.
COVID-19 Tissue and Data Repository
/in Currently EnrollingThis study is collecting blood samples and clinical data for storage in a repository from individuals who have received/plan to receive a vaccine against SARS-CoV-2. This study is currently enrolling participants.
REGN COV-2069
/in Completed StudiesThis study is assessing antibodies for the prevention of SARS CoV-2 infection of asymptomatic healthy adults.
COV1001
/in Completed StudiesThis study is assessing two different dosages of an investigational COVID-19 vaccine in healthy adults. This trial completed enrollment in August 2020 and is ongoing.
Ascent – IPCAVD012/HVTN118
/in Completed StudiesThis study is evaluating different vaccine regimens using experimental HIV vaccines in healthy HIV-negative adults. The study finished enrollment in September 2017 and is ongoing.
Z002
/in Completed StudiesThis study assessed two different dosages of an investigational Zika Virus vaccine in healthy adults. The study closed enrollment in September 2018. Data analysis is underway.
IPCAVD010
/in Completed StudiesThis study assessed different vaccine schedules using two experimental HIV vaccines in healthy HIV-negative adults. The study started in March 2016 and was completed in January 2019.
Z001
/in Completed StudiesThis study evaluated different vaccine schedules using an investigational Zika Virus vaccine in healthy adults. The study started in October 2016 and was completed in June 2018.
T001
/in Completed StudiesThis study assessed different dosages of a monoclonal antibody in healthy HIV-negative and healthy HIV-positive adults. The study closed enrollment in October 2018.
Center for Virology and Vaccine Research
3 Blackfan Circle
Boston, MA 02115 – USA
T 617.667.7000
F 617.735.4566
E CVVRcontact@bidmc.harvard.edu
CVVR Clinical Trials Unit
T 617.735.4610
E CVVRtrials@bidmc.harvard.edu